These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7089422)

  • 1. The influence of autologous sera and various drugs on the migration inhibition induced by vascular extracts in patients with coronary and peripheral arteriosclerosis.
    Gerö S; Horváth M; Szondy E
    Ric Clin Lab; 1982; 12(1):127-35. PubMed ID: 7089422
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of autologous serum, Oradexon and heparin on the cell-mediated immune response in vascular diseases.
    Horváth M; Szondy E; Ladányi A
    Clin Exp Immunol; 1980 Sep; 41(3):521-6. PubMed ID: 7438565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological studies with aortic and venous tissue antigens. II. Antibodies to vascular antigens.
    Gero S; Szekely J; Szondy E; Seregelyi E
    Paroi Arterielle; 1975 Dec; 3(2):89-92. PubMed ID: 1234649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of azathioprine, clofibrate and tribenoside on leucocyte migration inhibition induced by vascular antigens in vascular disease.
    Horváth M; Varsányi M; Ladányi A; Jósfay A
    Allergol Immunopathol (Madr); 1982; 10(1):25-32. PubMed ID: 6896255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymphocyte blast transformation and leukocyte migration inhibition as indices of sensitization in atherosclerosis of the coronary arteries of the heart].
    Selivanov II; Khardaev EK
    Sov Med; 1979 Jan; (1):35-40. PubMed ID: 424858
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the occurrence of circulating immune complexes in vascular diseases.
    Füst G; Szondy E; Székely J; Nánai I; Gerö S
    Atherosclerosis; 1978 Feb; 29(2):181-90. PubMed ID: 646847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated and humoral immune response in various vascular diseases.
    Horváth M; Onody C; Gerö S
    Allergol Immunopathol (Madr); 1980; 8(2):81-6. PubMed ID: 7457288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune reactions in vascular diseases].
    Horváth M; Onody K; Gerö S
    Orv Hetil; 1979 Sep; 120(39):2351-7. PubMed ID: 523118
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of Etofibrate (Lipo-Merz) on "in vitro" cellular immune response and on lipid parameters of men with myocardial infarction and with arteriosclerosis obliterans.
    Horváth M; Varsányl M; Jovanovich N; Romics L; Gerö S
    Allergol Immunopathol (Madr); 1990; 18(2):95-9. PubMed ID: 2371944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of autoallergic reactions for evaluating the immune status of patients with acute coronary insufficiency].
    Dvorkin MI
    Zdravookhr Kirg; 1979; (1):10-5. PubMed ID: 35891
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta-lipoprotein reaction with blood serum in cardiovascular diseases].
    Golod IS
    Sov Med; 1972 Jun; 35(6):22-5. PubMed ID: 4585122
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of leucocyte migration by stimulated mononuclear cell supernatants from patients with ischaemic heart disease.
    Das SK; Stein LD; Thebert PJ; Reynolds RT; Cassidy JT
    Br Heart J; 1983 Apr; 49(4):381-7. PubMed ID: 6830672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic shifts at different stages of coronary disease].
    Kitaev MI; Dvorkin MI
    Kardiologiia; 1984 Feb; 24(2):86-9. PubMed ID: 6716786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of clofibrate and pyridinol carbamate on the circulating immune complexes and cellular immune response in experimental atherosclerosis.
    Szondy E; Horváth M; Füst G; Link E; Fehér J; Gerö S
    Atherosclerosis; 1978 Nov; 31(3):251-7. PubMed ID: 718735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of clofibrate (Miscleron) and pyridinol carbamate (Prodectin) on immunologic factors in experimental arteriosclerosis].
    Szondy E; Horváth M; Füst G; Fehér J; Link E; Gerö S
    Orv Hetil; 1979 Jun; 120(23):1391-2. PubMed ID: 492681
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of circulating immune complexes in vascular diseases (preliminary report)].
    Füst G; Székely J; Szondy E; Gerö S
    Orv Hetil; 1977 Jun; 118(26):1520-3. PubMed ID: 876637
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes induced by vascular antigens in the aorta of guinea-pigs: immunological and morphological studies.
    Fehér J; Horváth M; Fehér E; Szondy E; Onody K; Gerö S
    Br J Exp Pathol; 1978 Jun; 59(3):237-47. PubMed ID: 678441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The incidence of serum factor, reacting with homologous antigen, in arteriosclerotic patients].
    Székely J; Dóbiás G; Szécsey G
    Orv Hetil; 1969 Jun; 110(24):1365-7. PubMed ID: 5792733
    [No Abstract]   [Full Text] [Related]  

  • 19. Age-related occurrence of antibodies to cardiac tissue and vessels in the sera of healthy persons and patients with atherosclerosis.
    Golod IS
    Mech Ageing Dev; 1973; 2(4):333-43. PubMed ID: 4798360
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immune response against lipoproteins in arteriosclerosis].
    Szondy E; Horváth M; Mezey Z; Székely J; Lengyel E; Füst G
    Orv Hetil; 1983 Dec; 124(52):3163-6. PubMed ID: 6657262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.